KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,487 | -85.4% | 24,990 | -80.5% | 0.00% | – |
| Q2 2023 | $228,923 | -52.2% | 127,890 | +3.8% | 0.00% | -100.0% |
| Q1 2023 | $479,275 | +13.4% | 123,207 | -0.9% | 0.00% | 0.0% |
| Q4 2022 | $422,640 | -15.5% | 124,306 | +35.7% | 0.00% | 0.0% |
| Q3 2022 | $500,000 | +22.5% | 91,580 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $408,000 | -38.3% | 90,482 | +0.8% | 0.00% | 0.0% |
| Q1 2022 | $661,000 | +6.3% | 89,741 | -7.2% | 0.00% | 0.0% |
| Q4 2021 | $622,000 | +21.5% | 96,698 | +9.9% | 0.00% | 0.0% |
| Q3 2021 | $512,000 | -50.0% | 87,951 | -11.4% | 0.00% | 0.0% |
| Q2 2021 | $1,025,000 | -7.8% | 99,284 | -6.1% | 0.00% | 0.0% |
| Q1 2021 | $1,112,000 | -32.3% | 105,734 | -0.4% | 0.00% | -50.0% |
| Q4 2020 | $1,643,000 | +6.1% | 106,130 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,549,000 | -22.6% | 106,130 | +0.4% | 0.00% | -50.0% |
| Q2 2020 | $2,002,000 | +15.1% | 105,721 | +16.7% | 0.00% | 0.0% |
| Q1 2020 | $1,740,000 | -0.3% | 90,557 | -0.5% | 0.00% | +33.3% |
| Q4 2019 | $1,745,000 | +98.1% | 91,006 | -0.6% | 0.00% | +50.0% |
| Q3 2019 | $881,000 | +65.3% | 91,558 | +3.0% | 0.00% | +100.0% |
| Q2 2019 | $533,000 | +20.3% | 88,923 | +17.1% | 0.00% | 0.0% |
| Q1 2019 | $443,000 | -37.7% | 75,930 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $711,000 | -43.7% | 75,930 | +2.4% | 0.00% | 0.0% |
| Q3 2018 | $1,263,000 | +0.2% | 74,167 | -0.0% | 0.00% | -33.3% |
| Q2 2018 | $1,261,000 | +73.7% | 74,193 | +37.1% | 0.00% | +50.0% |
| Q1 2018 | $726,000 | +42.1% | 54,111 | +1.6% | 0.00% | +100.0% |
| Q4 2017 | $511,000 | -15.0% | 53,278 | -2.6% | 0.00% | 0.0% |
| Q3 2017 | $601,000 | +10.9% | 54,693 | -8.6% | 0.00% | 0.0% |
| Q2 2017 | $542,000 | -20.9% | 59,844 | +12.2% | 0.00% | 0.0% |
| Q1 2017 | $685,000 | +30.5% | 53,344 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $525,000 | +8.2% | 55,844 | +12.0% | 0.00% | 0.0% |
| Q3 2016 | $485,000 | +46.1% | 49,844 | +0.6% | 0.00% | 0.0% |
| Q2 2016 | $332,000 | -24.9% | 49,544 | -0.1% | 0.00% | 0.0% |
| Q1 2016 | $442,000 | -22.2% | 49,591 | +15.8% | 0.00% | 0.0% |
| Q4 2015 | $568,000 | +28.2% | 42,832 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $443,000 | -61.4% | 42,080 | -0.2% | 0.00% | -66.7% |
| Q2 2015 | $1,148,000 | +38.6% | 42,180 | +56.0% | 0.00% | +50.0% |
| Q1 2015 | $828,000 | -12.0% | 27,037 | +7.6% | 0.00% | 0.0% |
| Q4 2014 | $941,000 | +7.5% | 25,137 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $875,000 | -16.8% | 25,030 | +10.8% | 0.00% | -33.3% |
| Q2 2014 | $1,052,000 | +139.6% | 22,600 | +59.2% | 0.00% | +200.0% |
| Q1 2014 | $439,000 | +35.1% | 14,200 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $325,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |